STRATA Skin Sciences, Inc.
SSKN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.6% | -7.8% | 20.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.9% | 55.3% | 60.2% | 66.2% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -8.5% | -10.1% | 3.1% | 5.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -30.1% | -32.5% | -15.3% | -9% |
| EPS Diluted | -0.26 | -0.31 | -0.16 | -0.08 |
| % Growth | 16.1% | -93.8% | -101.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |